Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass.
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
- المؤلفون: Keymeulen, B; Walter, M; Mathieu, C; Kaufman, L.; Gorus, F; Hilbrands, Robert; Vandemeulebroucke, Evy; Van de Velde, U; Crenier, Laurent; De Block, Christophe; Candon, Sophie; Waldmann, Herman; Ziegler, A G; Chatenoud, Lucienne; Pipeleers, D
- المصدر:
Diabetologia, 53 (4
- نوع التسجيلة:
Electronic Resource
- الدخول الالكتروني :
https://dipot.ulb.ac.be/dspace/bitstream/2013/141736/3/doi_125136.pdf
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/141736
https://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLL
- معلومة اضافية
- Publisher Information:
2010-04
- نبذة مختصرة :
The aim of the study was to examine the 48 month outcome of treating recent-onset type 1 diabetic patients for 6 days with humanised CD3-antibody, ChAglyCD3.
Clinical Trial, Phase II
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
info:eu-repo/semantics/published
- الموضوع:
- Availability:
Open access content. Open access content
1 full-text file(s): info:eu-repo/semantics/restrictedAccess
- Note:
1 full-text file(s): application/pdf
English
- Other Numbers:
EQY oai:dipot.ulb.ac.be:2013/141736
uri/info:doi/10.1007/s00125-009-1644-9
uri/info:pmid/20225393
uri/info:scp/77949266510
1363739764
- Contributing Source:
UNIVERSITE LIBRE DE BRUXELLES
From OAIster®, provided by the OCLC Cooperative.
- الرقم المعرف:
edsoai.on1363739764
HoldingsOnline
No Comments.